Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
Mayo Clinic Hospital in Arizona, Phoenix, Arizona Mayo Clinic in Florida, Jacksonville, Florida Dana-Farber Cancer Institute, Boston, Massachusetts Mayo Clinic in Rochester, Rochester, Minnesota University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania